Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
175,611,455
-
Total 13F shares
-
121,126,183
-
Share change
-
+6,219,530
-
Total reported value
-
$22,012,348,244
-
Put/Call ratio
-
191%
-
Price per share
-
$181.75
-
Number of holders
-
861
-
Value change
-
+$1,072,735,934
-
Number of buys
-
438
-
Number of sells
-
397
Institutional Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) as of Q1 2021
As of 31 Mar 2021,
Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) was held by
861 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
121,126,183 shares.
The largest 10 holders included
ARK Investment Management LLC, VANGUARD GROUP INC, BlackRock Inc., BAILLIE GIFFORD & CO, General Catalyst Group Management, LLC, Capital World Investors, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., BANK OF AMERICA CORP /DE/, and Discovery Value Fund.
This page lists
871
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.